Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Genetically Engineered Skin Cells Inhibit Microbial Infection

By Biotechdaily staff writers
Posted on 19 Jan 2007
Genetically engineered skin cells (keratinocytes) enhance the ability of grafted skin to prevent bacterial infections during the early stages of burn healing.

Investigators from the University of Cincinnati (Cincinnati, OH, USA) used advanced genetic engineering techniques to induce the expression of human beta defensin 4 in cultured primary epidermal keratinocytes. More...
Defensins are cationic peptides of the innate host defense system that have antimicrobial activity against many of the microorganisms commonly found in burn units.

The altered skin cell cultures were exposed to infection by Pseudomonas aeruginosa. Results published in the January 2007 issue of the Journal of Burn Care and Research revealed that skin cell cultures expressing human beta defensin 4 showed significantly elevated antimicrobial activity against clinically-isolated P aeruginosa as compared to cultures of normal keratinocytes.

"Cultured skin substitutes are improving the lives of many burn patients, but they also have limitations--including an increased susceptibility to infection,” explained senior author Dr. Dorothy Supp, associate professor of medicine at the University of Cincinnati. "If we can add these genetically modified cells to bio-engineered skin substitutes, it would provide an important defense system boost during the initial grafting period, when the skin is most susceptible to infection.”



Related Links:
University of Cincinnati

New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Gold Member
Aspiration System
VACUSAFE
New
Automated Urinalysis Solution
UN-9000
New
Total Laboratory Automation Solution
SATLARS Mini T8
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.